GSK, CureVac Expand Licensing Agreement
Wall Street Journal
Under a new licensing deal with CureVac, GSK will acquire full rights to develop, manufacture and commercialize internationally messenger RNA, or mRNA, candidate vaccines for influenza and Covid-19.
https://www.wsj.com/articles/gsk-curevac-expand-licensing-agreement-d1283c5d